Oncolytics Biotech Inc (ONC.TO)
1.59
-0.10
(-5.92%)
CAD |
TSX |
May 10, 16:00
Oncolytics Biotech EPS Diluted (Quarterly): -0.05 for Dec. 31, 2023
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -0.05 |
September 30, 2023 | -0.14 |
June 30, 2023 | -0.12 |
March 31, 2023 | -0.1006 |
December 31, 2022 | -0.15 |
September 30, 2022 | -0.08 |
June 30, 2022 | -0.09 |
March 31, 2022 | -0.12 |
December 31, 2021 | -0.14 |
September 30, 2021 | -0.09 |
June 30, 2021 | -0.13 |
March 31, 2021 | -0.13 |
December 31, 2020 | -0.22 |
September 30, 2020 | -0.16 |
June 30, 2020 | -0.17 |
March 31, 2020 | -0.04 |
December 31, 2019 | -0.83 |
September 30, 2019 | -0.16 |
June 30, 2019 | -0.26 |
March 31, 2019 | -0.27 |
December 31, 2018 | -0.28 |
September 30, 2018 | -0.20 |
June 30, 2018 | -0.27 |
March 31, 2018 | -0.31 |
December 31, 2017 | -0.32 |
Date | Value |
---|---|
September 30, 2017 | -0.20 |
June 30, 2017 | -0.32 |
March 31, 2017 | -0.285 |
December 31, 2016 | -0.44 |
September 30, 2016 | -0.285 |
June 30, 2016 | -0.19 |
March 31, 2016 | -0.285 |
December 31, 2015 | -0.285 |
September 30, 2015 | -0.19 |
June 30, 2015 | -0.285 |
March 31, 2015 | -0.38 |
December 31, 2014 | -0.38 |
September 30, 2014 | -0.475 |
June 30, 2014 | -0.475 |
March 31, 2014 | -0.57 |
December 31, 2013 | -0.665 |
September 30, 2013 | -0.665 |
June 30, 2013 | -0.57 |
March 31, 2013 | -0.76 |
December 31, 2012 | -1.045 |
September 30, 2012 | -1.14 |
June 30, 2012 | -1.235 |
March 31, 2012 | -1.045 |
December 31, 2011 | -1.52 |
September 30, 2011 | -0.855 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Quarterly) Range, Past 5 Years
-0.83
Minimum
Dec 2019
-0.04
Maximum
Mar 2020
-0.1674
Average
-0.13
Median
Mar 2021
EPS Diluted (Quarterly) Benchmarks
Biocure Technology Inc | -0.0014 |
Core One Labs Inc | -0.02 |
Nova Mentis Life Science Corp | -0.0013 |
Nanosphere Health Sciences Inc | -0.0054 |
Lobe Sciences Ltd | -0.01 |
EPS Diluted (Quarterly) Related Metrics
Net Income (Quarterly) | -3.949M |
Total Expenses (Quarterly) | 8.849M |
Enterprise Value | 85.01M |
Earnings Yield | -25.82% |